www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
 OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
PRESS RELEASES
ANNUAL REPORTS
CONTACT

CPEX Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company in the business of development, licensing and commercialization of pharmaceutical products utilizing our validated drug delivery technology. Our technology enhances permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa and eye through formulation development with proprietary molecules such as CPE-215®. We have licensed an application of our drug delivery technology to Auxilium Pharmaceuticals, which led to the launch of Testim® in the United States in February 2003, the first product incorporating our technology.
 
Chad Rubin
Vice President
The Trout Group, LLC
740 Broadway, 9th Floor
New York, NY 100003
TEL: 646.387.2947
FAX: 646.378.2901
Robert Hebert
Vice President and CFO
TEL: 603.658.6100
FAX: 603.658.6101
 
 
AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS
 
MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS
 
MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101